< Back to latest news & events

News

Coronavirus update – HGF offices

July 2020

The situation across the world is changing rapidly and as a result we have put in place measures to ensure that we are able to continue to provide the high-quality services to our clients whilst also protecting our staff, other stakeholders and suppliers.

This page provides information on any HGF office closures that may happen as a result of Coronavirus safety measures in Europe and the UK.

Updated 2nd July 2020

Aberdeen – Fully operational – Office closed with all staff working remotely

Amsterdam – Fully operational – Office open with majority of staff working remotely

Basel – Fully operational – Office open with majority of staff working remotely

Bern – Fully operational – Office open with majority of staff working remotely

Birmingham – Fully operational – Office closed with all staff working remotely

Dublin – Fully operational – Office closed with all staff working remotely

Edinburgh – Fully operational – Office closed with all staff working remotely

Glasgow – Fully operational – Office closed with all staff working remotely

Heidelberg – Fully operational – Office open with majority of staff working remotely

Leeds – Fully operational – Office closed with all staff working remotely

London – Fully operational – Office closed with all staff working remotely

Manchester – Fully operational – Office closed with all staff working remotely

Munich – Neumarkter Str – Fully operational – Office open with majority of staff working remotely

Munich – Uhlandstr. – Fully operational – Office open with majority of staff working remotely

Newcastle – Fully operational – Office closed with all staff working remotely

Nottingham – Fully operational – Office closed with all staff working remotely

Oxford – Fully operational – Office closed with all staff working remotely

Salzburg – Fully operational – Office open with majority of staff working remotely

Sheffield – Fully operational – Office closed with all staff working remotely

The Hague – Fully operational – Office open with majority of staff working remotely

Westport – Fully operational – Office closed with all staff working remotely

York – Fully operational – Office closed with all staff working remotely

If you need any urgent assistance, please call us on +44(0) 113 233 0100.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

WIPR Diversity Top 100 2025

HGF’s European Patent Attorney Alexandra Wood has been listed in World IP Review’s (WIPR) Diversity Top 100 2025 World IP Review’s Diversity in IP listings 2025 recognises and celebrates people …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article